Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Breast Cancer

Explore clinical trials studying Locally Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

50 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced Breast Cancer trial results

Completed

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

NCT04699630

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Florida Cancer Specialists-South Fort Myers, Florida, United States
View Trial Details
Completed

A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer

NCT05963997

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
  • Site 42 - Dana-Farber Cancer Institute, EDDC Boston, Massachusetts, United States
  • Site 35 - Cleveland Clinic, Taussig Cancer Institute Cleveland, Ohio, United States
  • Site 41 - The START Center for Cancer Care, South Texas Oncology and Hematology San Antonio, Texas, United States
View all 23 locations
View Trial Details
Completed

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

NCT05415215

Conditions
Behavior, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Centro de Investigaciones Médicas y Desarrollo LC S.R.L Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina
  • Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
  • University Clinical Center of the Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • Cantonal Hospital Zenica Zenica, Bosnia and Herzegovina
View all 45 locations
View Trial Details
Completed

A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

NCT05963984

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Ocala Oncology Center PL DBA Florida Cancer Affiliates Ocala, Florida, United States
  • Mfsmc-Hjwci Baltimore, Maryland, United States
  • Saint Luke's Cancer Institute Kansas City, Missouri, United States
  • Sidney Kimmel Cancer Center - Jefferson Health Philadelphia, Pennsylvania, United States
View all 32 locations
View Trial Details
Completed

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

NCT05002868

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Multiscan s.r.o. Hořovice, Czechia
  • SP ZOZ University Hospital in Krakow Oncology Clinic, 50 Kopernika Street Krakow, Poland
  • Klinika Onkologii ICZMP Lodz, Poland
  • Pratia Poznań Medical Center Poznan, Poland
View Trial Details
Completed

A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

NCT02595762

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • Bank of Cyprus Oncology Center Nicosia, Cyprus
  • Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine Athens, Greece
  • Anticancer Hospital Ag. Savas ; 2Nd Dept. of Oncology - Internal Medicine Athens, Greece
  • ARETAIEION UNIVERSITY HOSPITAL; oncology unit Athens, Greece
View Trial Details

Related conditions